Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Multicenter, Phase III, Prospective, Randomized, Double-blind, Comparative Study to Evaluate the Efficacy and Tolerability of Venaflon Use in Reducing the Symptoms Caused by Chronic Venous Insufficiency When Compared With Daflon

NCT01477281 is registered in ClinicalTrials.gov with Laboratório Teuto Brasileiro S/A as lead sponsor.

NCT NCT01477281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01477281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Multicenter, Phase III, Prospective, Randomized, Double-blind, Comparative Study to Evaluate the Efficacy and Tolerability of Venaflon Use in Reducing the Symptoms Caused by Chronic Venous Insufficiency When Compared With Daflon
Lead sponsor
Laboratório Teuto Brasileiro S/A
Phase
Phase 3
Overall status
Unknown status
Start date
February 29, 2012
Completion date
August 31, 2012
Enrollment
82 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic venous insufficiency, disease